University of Cincinnati Feb 3 2026 A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory molecule to stimulate the central nervous system (CNS) immune system after surgery to remove glioblastoma, a form of primary brain cancer. Jonathan Forbes, MD, the project's principal investigator, explained glioblastomas are the most common type of primary cancer